Found 77 results
Author Title Type [ Year(Asc)]
Filters: Author is Van Veldhuisen, P  [Clear All Filters]
2016
L. T. Wu, McNeely, J., Subramaniam, G. A., Sharma, G., Van Veldhuisen, P., and Schwartz, R. P., “Design of the NIDA Clinical Trials Network Validation Study of Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse (TAPS) Tool”, Contemp Clin Trials, vol. 50, pp. 90-97, 2016.
L. R. Metsch, Feaster, D. J., Gooden, L., Matheson, T., Stitzer, M., Das, M., Jain, M. K., Rodriguez, A. E., Armstrong, W. S., Lucas, G. M., Nijhawan, A. E., Drainoni, M., Herrera, P., Vergara-Rodriguez, P., Jacobson, J. M., Mugavero, M. J., Sullivan, M., Daar, E. S., McMahon, D. K., Ferris, D. C., Lindblad, R., Van Veldhuisen, P., Oden, N., Castellón, P. C., Tross, S., Haynes, L. F., Douaihy, A., Sorensen, J. L., Metzger, S., Mandler, R. N., Colfax, G. N., and del Rio, C., “Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial”, JAMA, vol. 316, no. 2, pp. 156-170, 2016.
G. Sharma, Oden, N., Van Veldhuisen, P., and Bogenschutz, M., “Hair Analysis and its Concordance with Self-Report for Drug Users Presenting in Emergency Department”, Drug Alcohol Depend, 2016.
N. Oden and Van Veldhuisen, P., “Interim Monitoring of Non-inferiority Trials”, in Society for Clinical Trials (SCT) 37th Annual Meeting, Montreal, Quebec, Canada, 2016.
L. Yesko, Hoehn, A., Van Veldhuisen, P., Schwartz, R., McNeely, J., Wu, L., Sherritt, L., and Subramaniam, G., “Lessons Learned In Collecting Participant Reported Outcome Data via Web-Based Data Systems”, in Society for Clinical Trials (SCT) 37th Annual Meeting, Montreal, Quebec, Canada, 2016.
R. Lindblad, Hu, L., Oden, N., Wakim, P., Rosa, C., and Van Veldhuisen, P., “Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network”, J Subst Abuse Treat, vol. 70, pp. 73-80, 2016.
R. Lindblad, Saxon, A., Van Veldhuisen, P., Lu, L., Hu, L., Hasson, A., Thomas, C., Sparenborg, S., Mooney, L., and Ling, W., “Safety of Combination Buprenorphine/Naloxone and Extended Release Naltrexone”, in 2016 CPDD Scientific Meeting, Palm Springs, CA, 2016.
2014
E. McClure, Sonne, S., Winhusen, T., Carroll, K., Ghitza, U., McRae-Clark, A., Matthews, A., Sharma, G., Van Veldhuisen, P., Vandrey, R., Levin, F., Weiss, R., Lindblad, R., Allen, C., Mooney, L., Haynes, L., Brigham, G., Sparenborg, S., Hasson, A., and Gray, K., “Achieving Cannabis Cessation – Evaluating N-Acetylcysteine Treatment (ACCENT): Design and Implementation of a Multi-Site, Randomized Controlled Study in the National Institute on Drug Abuse Clinical Trials Network”, Contemp Clin Trials, vol. 39, pp. 211-223, 2014.
C. A. Allen, Yesko, L., and Van Veldhuisen, P., “Implications of Modifying Study Eligibility Criteria Post-Initiation of Recruitment”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
A. N. Campbell, Nunes, E. V., Matthews, A. G., Stitzer, M., Miele, G. M., Polsky, D., Turrigiano, E., Walters, S., McClure, E. A., Kyle, T. L., Wahle, A., Van Veldhuisen, P., Goldman, B., Babcock, D., Stabile, P. Q., Winhusen, T., and Ghitza, U. E., “Internet-Delivered Treatment for Substance Abuse: A Multisite Randomized Controlled Trial”, Am J Psychiatry, vol. 171, pp. 683-690, 2014.
T. M. Winhusen, Kropp, F., Lindblad, R., Douaihy, A., Haynes, L., Hodgkins, C., Chartier, K., Kampman, K. M., Sharma, G., Lewis, D. F., Van Veldhuisen, P., Theobald, J., May, J., and Brigham, G. S., “Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence”, J Clin Psychiatry, vol. 75, pp. 757-764, 2014.
S. Haberman, Saraf, S., Zhang, J., Landy, H. J., Branch, D. W., Burkman, R., Gregory, K. D., Ramirez, M. M., Bailit, J. L., Gonzalez-Quintero, V. H., Hibbard, J. U., Hoffman, M. K., Kominiarek, M., Lu, L., Van Veldhuisen, P., and Von Gruenigen, V., “Non Clinical Parameters Affecting Primary Cesarean Rates in the United States”, Am J Perinatol, vol. 31, pp. 213-222, 2014.
B. Tai, Hu, L., Ghitza, U. E., Sparenborg, S., Van Veldhuisen, P., and Lindblad, R., “Patient Registries for Substance Use Disorders”, Subst Abuse Rehabil, vol. 5, pp. 81-86, 2014.
G. Sharma, Van Veldhuisen, P., and Allen, C. A., “Tracking and Monitoring Trial Progress in NIDA CTN Studies”, in NIH Workshop on Enrollment and Retention of Participants in NIH-funded Clinical Trials, Bethesda, MD, 2014.
2013
A. Matthews, Hu, L., Lu, L., and Van Veldhuisen, P., “Body Mass Index (BMI) and Obesity Prevalence Among Substance Abuse Participants from NIDA’s Clinical Trials Network (CTN)”, in College on Problems of Drug Dependence Meeting, San Diego, CA, 2013.
R. Lindblad, McCormack, J., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Mooney, L., Van Veldhuisen, P., and Ling, W., “Induction onto Extended-release Naltrexone in 302 Cocaine-dependent Opioid Users”, in College on Problems of Drug Dependence Meeting, San Diego CA, 2013.
M. Figueroa, Gupte, S., McCormack, J., Salazar, D., Van Veldhuisen, P., and Wahle, A., “Investigator Attestation Poster”, in Society of Clinical Research Associates - SoCRA, 22nd Annual Conference, 2013.
D. B. Shmueli-Blumberg, Hu, L. H., Allen, C. A., Frasketi, M. F., Wu, L., and Van Veldhuisen, P., “The National Drug Abuse Treatment Clinical Trials Network Data Share Project: Website Design, Usage, Challenges, and Future Directions”, Clin Trials, vol. 10, pp. 977-986, 2013.
D. Weinberg, Wahle, A., Ip, M., Scott, I., Van Veldhuisen, P., and Blodi, B., “SCORE Study Report 12: Development of Venous Collaterals in the SCORE Study”, Retina, vol. 33, pp. 287-295, 2013.
2012
R. Lindblad, Campanella, M., Van Veldhuisen, P., and Allen, C., “Clinical Trial Management: Monitoring Progress, Sites and Safety; New Paradigms for Efficiency”, in 5th Annual Clinical Research Management Workshop at the Yale Center for Clinical Investigation, New Haven, CT, 2012.
J. L. Wiggs, Yaspan, B. L., Hauser, M. A., Kang, J. H., Allingham, R. R., Olson, L. M., Abdrabou, W., Fan, B. J., Wang, D. Y., Brodeur, W., Budenz, D. L., Caprioli, J., Crenshaw, A., Crooks, K., Delbono, E., Doheny, K. F., Friedman, D. S., Gaasterland, D., Gaasterland, T., Laurie, C., Lee, R. K., Lichter, P. R., Loomis, S., Liu, Y., Medeiros, F. A., McCarty, C., Mirel, D., Moroi, S. E., Musch, D. C., Musch, D. C., Realini, A., Rozsa, F. W., Schuman, J. S., Scott, K., Singh, K., Stein, J. D., Trager, E. H., Van Veldhuisen, P., Vollrath, D., Wollstein, G., Yoneyama, S., Zhang, K., Weinreb, R. N., Ernst, J., Kellis, M., Masuda, T., Zack, D., Richards, J. E., Pericak-Vance, M., Pasquale, L. R., and Haines, J. L., “Common Variants at 9p21 and 8q22 are Associated with Increased Susceptibility to Optic Nerve Degeneration in Glaucoma”, PLoS Genet, vol. 8, no. 4, p. e1002654, 2012.
A. Campbell, Nunes, E. V., Miele, G. M., Matthews, A., Polsky, D., Ghitza, U., Turrigiano, E., Bailey, G. L., Van Veldhuisen, P., Chapdelaine, R., Froias, A., Stitzer, M. L., Carroll, K. M., Winhusen, T., Clingerman, S., Perez, L., McClure, E., Goldman, B., and Crowell, A. R., “Design and Methodological Considerations of an Effectiveness Trial of a Computer-Assisted Intervention: An Example from the NIDA Clinical Trials Network”, Contemp Clin Trials, vol. 33, pp. 386-395, 2012.
R. Lindblad, Hu, L., Campanella, M., Kondapaka, R., Rosa, C., Allen, C., Oden, N., and Van Veldhuisen, P., “Estimating Death Rates In Substance Use Disorder”, in The Society for Clinical Trials 33rd Annual Meeting, Miami, FL, 2012.
T. Winhusen, Brady, K. T., Stitzer, M., Woody, G., Lindblad, R., Kropp, F., Brigham, G., Liu, D., Sparenborg, S., Sharma, G., Van Veldhuisen, P., Adinoff, B., and Somoza, E., “Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence: An Efficacy Trial Conducted in the Real World”, Contemp Clin Trials, vol. 33, pp. 993-1002, 2012.
S. Sparenborg, Hu, L., Van Veldhuisen, P., Allen, C., and Tai, B., “How Electronic Health Records (EHRs) Can Support Comparative Effectiveness Research (CER)”, in Annual Comparative Effectiveness Research Key Function Committee Meeting, Rockville, MD, 2012.